Scaffold-based design of kinase inhibitors for cancer therapy
Authors:
- 1 February 2010
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 20 (1) , 79-86
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Factors underlying sensitivity of cancers to small-molecule kinase inhibitorsNature Reviews Drug Discovery, 2009
- Kinase-targeted libraries: The design and synthesis of novel, potent, and selective kinase inhibitorsDrug Discovery Today, 2009
- Targeting cancer with small molecule kinase inhibitorsNature Reviews Cancer, 2009
- Crystal Structures of Proto-oncogene Kinase Pim1: A Target of Aberrant Somatic Hypermutations in Diffuse Large Cell LymphomaJournal of Molecular Biology, 2005
- A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug designNature Biotechnology, 2005
- Fragment-Based Lead Discovery Using X-ray CrystallographyJournal of Medicinal Chemistry, 2004
- Protein Kinase Inhibitors: Insights into Drug Design from StructureScience, 2004
- The Protein Kinase Complement of the Human GenomeScience, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001